Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

The Lancet

Volumn 342, Issue 8886-8887, 1993, Pages 1503-1506

  Koster, T ^a   Vandenbroucke, JP ^a   Rosendaal, FR ^a   de Ronde, H ^a   Briët, E ^a   Bertina, RM ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; FEMALE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; MIDDLE AGE; ODDS RATIO; PROTEIN C; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; THROMBOPHLEBITIS;

EID: 0027520285     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)80081-9     Document Type: Article

References (18)

1. Epidemiology and pathogenesis of venous thrombosis
2. Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C prediction of a cofactor to activated protein C
3. The regulation of hemostasis: the protein C system
4. Protein-C: biochemistry, physiology, and clinical implications
5. The effects of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C
6. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor
7. Twenty novel families with thrombophilia and inherited resistance to activated protein C
8. Novel mechanism for thrombosis characterised by poor anticoagulant response to activated protein C constitutes a major cause of thrombophilia
9. Some remarks on the epidemiology of thrombotic disorders
10. Anticoagulant control and the risk of bleeding: organizational infrastructure
11. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium
12. Two ELISAs for measurement of protein S and their use in the laboratory diagnosis of protein S deficiency
13. Estimatibility and estimation of case-referent studies
14. Absence of thrombosis in subjects with heterozygous protein C deficiency
15. Inherited predisposition to thrombosis
16. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency
17. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis